Japan has updated its regulations on human embryo research, aligning with international standards, effective April 2026. These changes come after the ISSCR revised its guidelines in 2025, sparking discussions on how embryo models can advance our understanding of early human development and infertility.
Japan's Regulatory Changes for Embryo Research
The revised guidelines unify oversight for all human embryo model research, closing previous regulatory gaps. This includes studies involving iPS cell-derived embryo models that were previously in a gray area. Now, all such research mandates an ethics review and notification to the national government.
Key features of the revised regulations include:
- Prohibition of transfer into a human or animal uterus
- Requirements for researchers to specify the minimum culture period needed
- Mandates for public availability of research findings
Comparative Analysis of Japanese and ISSCR Guidelines
While both Japan's and ISSCR's guidelines share common ground, including the prohibition of uterine transfer and organismal development, they differ significantly in defining human embryo models. The ISSCR recognizes some organoid models as human embryo research, whereas Japan maintains a distinction between organoids and embryo models.


